Associated Papers
Discriminating activating, deactivating and resistance variants in protein kinases.
Singh G et al.
Genome Medicine, 2025
41152984 (PubMed )
Supplement: 13073_2025_1564_MOESM2_ESM.xlsx › Table_S5
Deep mutational scanning of the human insulin receptor ectodomain to inform precision therapy for insulin resistance.
Aslanzadeh V et al.
Nature Communications, 2025
The ACE inhibitor captopril inhibits ACN-1 to control dauer formation and aging.
Egan BM et al.
Development (cambridge, England), 2024
The ACE-inhibitor drug captopril inhibits ACN-1 to control dauer formation and aging.
Egan BM et al.
Biorxiv : the Preprint Server for Biology, 2023
Genomic characterization of lymphomas in patients with inborn errors of immunity.
Ye X et al.
Blood Advances, 2022
35687490 (PubMed )
Supplement: advancesADV2021006654-suppl4.xlsx › PL17
Structural Basis and Genotype-Phenotype Correlations of INSR Mutations Causing Severe Insulin Resistance.
Hosoe J et al.
Diabetes, 2017
A novel class of somatic mutations in blood detected preferentially in CD8+ cells.
Valori M et al.
Clinical Immunology (orlando, Fla.), 2017
Sequencing analysis of insulin receptor defects and detection of two novel mutations in INSR gene.
Ardon O et al.
Molecular Genetics and Metabolism Reports, 2014
Six cases with severe insulin resistance (SIR) associated with mutations of insulin receptor: Is a Bartter-like syndrome a feature of congenital SIR?
Grasso V et al.
Acta Diabetologica, 2013
Resequencing analysis of the candidate tyrosine kinase and RAS pathway gene families in multiple myeloma.
Hucthagowder V et al.
Cancer Genetics, 2012
Genotype-phenotype correlation in inherited severe insulin resistance.
Longo N et al.
Human Molecular Genetics, 2002
Select a paper to view details